Barrett's Esophagus Clinical Trial
Official title:
Real-time Diagnosis of Barrett's Esophagus: Comparing Confocal Laser Endomicroscopy With Conventional Histology for the Identification of Specialized Intestinal Metaplasia
Real-time Diagnosis of Barrett's Esophagus: Comparing Confocal Laser Endomicroscopy with Conventional Histology for the Identification of Specialized Intestinal Metaplasia
The incidence of esophageal adenocarcinoma has risen over 800% over the past several decades
and is associated with a high mortality rate. Barrett's esophagus (BE) has been identified
as the number one risk factor for the development of esophageal adenocarcinoma.
Gastroesophageal reflux disease (GERD) has been identified as the major risk factor for
development of BE. Current guidelines for BE diagnosis and surveillance, according to the
Seattle protocol, include four-quadrant random biopsies at 2-cm intervals (1-cm intervals if
suspected high grade intraepithelial neoplasia). This random biopsy protocol can be
time-consuming, expensive, and prone to sampling error, as very little of the esophageal
surface area is actually sampled. Probe-based confocal laser endomicroscopy (pCLE) generates
optical biopsies, providing physicians with microscopic images of tissue instantaneously and
in a minimally invasive manner. Comparing pCLE with conventional histology for the
identification of specialized intestinal metaplasia has the potential to result in a new
standard of care for the diagnosis of BE. The aim of this study is to compare pCLE to
traditional tissue biopsies for the diagnosis of BE.
A patient with GERD will be scheduled for upper endoscopy as part of routine evaluation.
Routine endoscopy will be performed, including white light and narrow band imaging photo
documentation. Probe-based confocal laser endomicroscopy will be performed at the
gastroesophageal junction. Biopsies of columnar lined esophagus will then be taken in four
quadrants starting at the squamocolumnar junction and proceeding in 1 cm segments to the
gastroesophageal junction. Optical biopsy images will be reviewed immediately following
endoscopy by endoscopist and later reviewed by blinded independent reviewer. Pathology
specimens will be reviewed by a pathologist. The results of the optical biopsies obtained
with probe-based confocal laser endomicroscopy will be compared with the pathology results.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02864043 -
Barrett's Dysplasia Detection Pilot Trial Using the NvisionVLE® Imaging System
|
N/A | |
Recruiting |
NCT02018367 -
Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma
|
Phase 2 | |
Terminated |
NCT01572987 -
Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus
|
N/A | |
Terminated |
NCT01976351 -
Imaging Enhanced Endoscopy for the Screening of Barrett's Esophagus
|
N/A | |
Terminated |
NCT00526786 -
Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
|
Phase 4 | |
Completed |
NCT01401699 -
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
|
N/A | |
Completed |
NCT02106910 -
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
|
N/A | |
Suspended |
NCT01580631 -
Narrow Band Imaging Project on Barrett's Esophagus
|
||
Completed |
NCT01439633 -
Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus
|
N/A | |
Completed |
NCT02879721 -
Expression and Function of the Renin-Angiotensin System in the Esophagus
|
Phase 0 | |
Completed |
NCT01281618 -
Influence of Acid Reflux on Stromal Epithelial Interaction in Barrett's Esophagus
|
N/A | |
Completed |
NCT01439594 -
Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation
|
N/A | |
Completed |
NCT00586872 -
Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus
|
||
Completed |
NCT00844077 -
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
|
N/A | |
Completed |
NCT00588575 -
Ramanspectroscopy in Barrett's Esophagus
|
||
Recruiting |
NCT00288119 -
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
|
||
Completed |
NCT02579460 -
Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition
|
N/A | |
Completed |
NCT03813381 -
CAlorie and Protein REstriction PROgram in Barrett's Esophagus Patients (CARE-PRO).
|
N/A | |
Completed |
NCT01961778 -
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
|
N/A | |
Not yet recruiting |
NCT02033070 -
Patient Registry: Radio Frequency Ablation of Barrett's Esophagus Using HALO System
|
N/A |